[Form 4] Salesforce, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Salesforce, Inc. director Neelie Kroes reported equity award activity involving company common stock. On 11/22/2025, 274 shares of Salesforce common stock were acquired at a price of $0 per share following the vesting and conversion of restricted stock units. On the same date, 42 shares were disposed of at $227.11 per share to cover tax withholding obligations, leaving Kroes with 11,192 shares of Salesforce common stock held directly.

The derivative table shows that 274 restricted stock units, which convert to common stock on a one-for-one basis, were exercised at an exercise price of $0, resulting in no remaining derivative securities from this particular award. These restricted stock units vest in four equal installments of 25% of the original grant on February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KROES NEELIE

(Last) (First) (Middle)

415 MISSION STREET

3RD FLOOR

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/22/2025		M		274	A	$0	11,234	D
Common Stock	11/22/2025		F		42(1)	D	$227.11	11,192	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(2)	11/22/2025		M			274	02/22/2025(3)	11/22/2025	Common Stock	274	$0	0	D

Explanation of Responses:

1. Shares withheld to satisfy the reporting person's tax liability in connection with the issuance of common stock pursuant to the award reported in row 1 above.

2. Restricted Stock Units convert to shares of common stock on a one-for-one basis.

3. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

	/s/ Sarah Dale, Attorney-in-Fact for Neelie Kroes	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Salesforce (CRM) director Neelie Kroes report?

Neelie Kroes reported the acquisition of 274 shares of Salesforce common stock on 11/22/2025 from the vesting of restricted stock units, and the disposition of 42 shares on the same date.

How many Salesforce (CRM) shares does Neelie Kroes hold after this Form 4 transaction?

Following the reported transactions, Neelie Kroes beneficially owns 11,192 shares of Salesforce common stock held directly.

At what prices were Neelie Kroes’s Salesforce (CRM) transactions reported?

The 274 shares acquired on 11/22/2025 were reported at $0 per share, reflecting conversion of restricted stock units, while the 42 shares disposed of were reported at a price of $227.11 per share.

Why were 42 Salesforce (CRM) shares disposed of by Neelie Kroes?

The 42 shares were withheld and disposed of to satisfy tax liabilities associated with the issuance of common stock from the restricted stock unit award.

What are the terms of Neelie Kroes’s Salesforce restricted stock units reported here?

The restricted stock units convert to Salesforce common stock on a one-for-one basis and vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

Does this Salesforce (CRM) Form 4 involve derivative securities?

Yes. The filing reports 274 restricted stock units as derivative securities that were exercised at an exercise price of $0, converting into 274 shares of Salesforce common stock, leaving 0 derivative securities remaining from this award.